MarketCapTrends
CHRS
Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare

Coherus Biosciences Inc. Cash on Hand 2012–2025

Coherus Biosciences Inc. annual/quarterly cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Coherus Biosciences Inc. cash on hand for the quarter ending December 31, 2025 were 88.9M, a 29.45% decrease year-over-year.
  • Coherus Biosciences Inc. cash on hand for 2025 were 88.9M, a 29.45% decrease from 2024.
  • Coherus Biosciences Inc. cash on hand for 2024 were 126.0M, a 22.45% increase from 2023.
  • Coherus Biosciences Inc. cash on hand for 2023 were 102.9M, a 61.91% increase from 2022.
  • Coherus Biosciences Inc. cash on hand for 2022 were 63.5M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Coherus Biosciences Inc. Annual Cash on Hand (Millions of US $)
2025$89
2024$126
2023$103
2022$64
2021$417
2020$541
2019$178
2018$72
2017$127
2016$125
2015$158
2014$150
2013$40
Coherus Biosciences Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$89
2024-12-31$126
2023-12-31$103
2022-12-31$64
2021-12-31$417
2020-12-31$541
2019-12-31$178
2018-12-31$72
2017-12-31$127
2016-12-31$125
2015-12-31$158
2014-12-31$150
2013-12-31$40

Coherus Biosciences Inc. Cash on Hand — FAQ

Coherus Biosciences Inc. (CHRS) cash on hand over the last 14 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CHRS's cash on hand history?

The chart and table above show Coherus Biosciences Inc.'s cash on hand by year and by quarter, including the growth rate.